|
Volumn 5, Issue 4, 2007, Pages 868-870
|
von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2 [5]
c
HÔTEL DIEU
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COLLAGEN TYPE 3;
VON WILLEBRAND FACTOR;
BINDING ASSAY;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC KIT;
DIAGNOSTIC VALUE;
DOUBLE BLIND PROCEDURE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GENE IDENTIFICATION;
GENE MUTATION;
GENETIC CODE;
HUMAN;
INTERMETHOD COMPARISON;
LETTER;
MAJOR CLINICAL STUDY;
MUTATIONAL ANALYSIS;
PRIORITY JOURNAL;
PROTEIN DETERMINATION;
PROTEIN DOMAIN;
QUALITATIVE DIAGNOSIS;
QUANTITATIVE DIAGNOSIS;
REPRODUCIBILITY;
VON WILLEBRAND DISEASE;
BLOOD COAGULATION TESTS;
CASE-CONTROL STUDIES;
CHEMISTRY, CLINICAL;
COHORT STUDIES;
COLLAGEN TYPE III;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
HUMANS;
MODELS, BIOLOGICAL;
VON WILLEBRAND DISEASE;
VON WILLEBRAND FACTOR;
|
EID: 34147115746
PISSN: 15387933
EISSN: 15387836
Source Type: Journal
DOI: 10.1111/j.1538-7836.2007.02437.x Document Type: Letter |
Times cited : (7)
|
References (5)
|